Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
Korro Bio and Frequency Therapeutics’ Merger Agreement
Korro Bio’s $116 Million Series B Financing
Goodwin advised Korro Bio on the deal. Korro Bio, Inc. announced its $116 million Series B financing. Korro is an RNA editing company focused on discovery...